Equities

Protext Mobility Inc

TXTM:PKC

Protext Mobility Inc

Actions
TechnologyTechnology
  • Price (USD)0.0009
  • Today's Change0.000 / -4.26%
  • Shares traded1.30m
  • 1 Year change-18.18%
  • Beta-3.4094
Data delayed at least 15 minutes, as of Jun 07 2024 16:36 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Protext Mobility, Inc. is a biotech company, which is engaged in the development of a cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes and technologies. The Company is engaged in the research, testing and development of highly bioavailable botanical products all-natural ingredients formulated for nutraceutical and pharmaceutical applications through the use of proprietary live plant extraction technology. The Company’s subsidiaries include Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc.

  • Revenue in USD (TTM)750.00
  • Net income in USD-2.21m
  • Incorporated2010
  • Employees4.00
  • Location
    Protext Mobility Inc1100 Brickell Bay Drive 310747MIAMI 33231United StatesUSA
  • Phone+1 (516) 802-0223
  • Fax+1 (302) 655-5049
  • Websitehttp://ww1.protextm.co/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Entero Therapeutics Inc0.00-6.44m7.43m15.00--0.3379-----51.90-51.900.0038.450.00----0.00-12.74-295.92-14.01-1,599.51-----------265.690.0802-------7.55------
Paranovus Entertainment Technology Ltd51.46m-42.62m7.48m80.00--0.7009--0.1454-7.16-7.499.891.461.1859.614.15643,209.90-91.12-23.19-119.36-27.214.9223.09-77.15-24.253.97-2,465.220.00--9.689.80-45.84---21.93--
BioNexus Gene Lab Corp9.78m-2.66m7.51m30.00--0.8032--0.7678-0.14-0.140.6510.52891.018.555.80---27.53-3.83-33.16-5.0213.5614.55-27.25-3.043.98-162.450.00---10.60115.07-638.56--30.40--
Integrated BioPharma, Inc.50.57m-116.00k7.52m141.00--0.397935.490.1488-0.0041-0.00411.670.62831.884.4510.76358,617.00-0.43115.51-0.569827.947.0912.09-0.22946.441.02-9.000.001---9.913.00-101.35---14.03--
eFFECTOR Therapeutics Inc0.00-34.63m7.53m14.00--7.55-----13.31-13.310.000.21190.00----0.00-141.18-----------------17.120.9581---100.00---58.00------
Cadrenal Therapeutics Inc-100.00bn-100.00bn7.54m3.00------------------------------------------------------------
NuCana PLC (ADR)0.00-33.89m7.64m25.00--0.6368-----302.88-302.880.005.670.00----0.00-72.34-41.01-125.17-48.07------------0.0324------13.71---21.70--
National Graphite Corp0.00-1.97m7.72m0.00---------0.0221-0.02210.00-0.01930.00-------11,014.44-212.13---6,295.18---------------------1,432.70------
Chromocell Therapeutics Corp0.00-8.98m7.73m4.00--6.84-----1.66-1.660.000.1960.00----0.00-440.01-----------------7.200.00-------200.20------
Protext Mobility Inc750.00-2.21m7.91m4.00------10,549.47-0.4692-0.46920.00001-0.01020.0405-------9,400.97-1,587.94----86.67-530.19-232,392.00-17,498.830.0002-1.36-----93.98-63.0927.35------
Molecular Templates Inc31.76m-18.40m8.03m62.00--1.12--0.2529-4.36-4.365.981.090.6014--19.55512,306.40-34.83-51.78-54.80-73.14-----57.92-228.33---52.110.00--190.1033.9691.24---48.87--
GT Biopharma Inc0.00-9.64m8.09m2.00--0.9748-----7.04-7.040.003.850.00----0.00-64.24-205.36-90.39--------------0.00------63.62------
Endexx Corp4.64m6.93m8.15m--1.21--1.371.760.01330.01330.0091-0.02550.67734.3713.54--86.51------28.73--127.74--0.0664------228.66--28.26------
Odonate Inc0.00-102.07m8.33m137.00--307.35-----13.59-13.590.009.270.00----0.00-66.98-58.36-83.00-65.14------------0.00-------12.99------
Data as of Jun 07 2024. Currency figures normalised to Protext Mobility Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.